A total of seven days later, the tumor burden was evaluated based on bioluminescent imaging (BLI), and a group of five mice received a single dose of 1 × 106 or 2 × 106 of either Mock-T or ROR1 Hinge CAR-T through tail vein injection. This evidence concerns the gene ROR1 and neoplasm.